Wersinger SR

References (2)

Title : Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia - Kucinski_2011_Curr.Pharm.Biotechnol_12_437
Author(s) : Kucinski AJ , Stachowiak MK , Wersinger SR , Lippiello PM , Bencherif M
Ref : Curr Pharm Biotechnol , 12 :437 , 2011
Abstract :
PubMedSearch : Kucinski_2011_Curr.Pharm.Biotechnol_12_437
PubMedID: 21133847

Title : TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia - Hauser_2009_Biochem.Pharmacol_78(7)_803
Author(s) : Hauser TA , Kucinski A , Jordan KG , Gatto GJ , Wersinger SR , Hesse RA , Stachowiak EK , Stachowiak MK , Papke RL , Lippiello PM , Bencherif M
Ref : Biochemical Pharmacology , 78 :803 , 2009
Abstract :
PubMedSearch : Hauser_2009_Biochem.Pharmacol_78(7)_803
PubMedID: 19482012